Cargando…
Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138727/ https://www.ncbi.nlm.nih.gov/pubmed/35625665 http://dx.doi.org/10.3390/biom12050693 |
_version_ | 1784714691997597696 |
---|---|
author | Díaz-Talavera, Alberto Montero-Conde, Cristina Leandro-García, Luis Javier Robledo, Mercedes |
author_facet | Díaz-Talavera, Alberto Montero-Conde, Cristina Leandro-García, Luis Javier Robledo, Mercedes |
author_sort | Díaz-Talavera, Alberto |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9138727 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91387272022-05-28 Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248 Díaz-Talavera, Alberto Montero-Conde, Cristina Leandro-García, Luis Javier Robledo, Mercedes Biomolecules Correction MDPI 2022-05-12 /pmc/articles/PMC9138727/ /pubmed/35625665 http://dx.doi.org/10.3390/biom12050693 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Correction Díaz-Talavera, Alberto Montero-Conde, Cristina Leandro-García, Luis Javier Robledo, Mercedes Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248 |
title | Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248 |
title_full | Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248 |
title_fullStr | Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248 |
title_full_unstemmed | Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248 |
title_short | Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248 |
title_sort | correction: díaz-talavera et al. primpol: a breakthrough among dna replication enzymes and a potential new target for cancer therapy. biomolecules 2022, 12, 248 |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138727/ https://www.ncbi.nlm.nih.gov/pubmed/35625665 http://dx.doi.org/10.3390/biom12050693 |
work_keys_str_mv | AT diaztalaveraalberto correctiondiaztalaveraetalprimpolabreakthroughamongdnareplicationenzymesandapotentialnewtargetforcancertherapybiomolecules202212248 AT monterocondecristina correctiondiaztalaveraetalprimpolabreakthroughamongdnareplicationenzymesandapotentialnewtargetforcancertherapybiomolecules202212248 AT leandrogarcialuisjavier correctiondiaztalaveraetalprimpolabreakthroughamongdnareplicationenzymesandapotentialnewtargetforcancertherapybiomolecules202212248 AT robledomercedes correctiondiaztalaveraetalprimpolabreakthroughamongdnareplicationenzymesandapotentialnewtargetforcancertherapybiomolecules202212248 |